How could a genetic variant of the p22(phox) component of NAD(P)H oxidases contribute to the progression of coronary atherosclerosis?
Wolin
M S
MS
D001808:Blood Vessels / Q000378:metabolism / Q000502:physiology; D003324:Coronary Artery Disease / Q000503:physiopathology*; D018450:Disease Progression; D014644:Genetic Variation / Q000502:physiology*; D006801:Humans; D026901:Membrane Transport Proteins; D009154:Mutation / Q000502:physiology; D009252:NADPH Dehydrogenase / Q000235:genetics* / Q000502:physiology*; D019255:NADPH Oxidases; D010586:Phagocytes / Q000502:physiology; D010750:Phosphoproteins / Q000235:genetics* / Q000502:physiology*
D026901:Membrane Transport Proteins; D010750:Phosphoproteins; D019255:NADPH Oxidases; C086986:CYBA protein, human; D009252:NADPH Dehydrogenase